Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noninvasive Aspergillus pulmonary disease.

Marc A Judson1

  • 1Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, South Carolina, USA. judsonma@MUSC.edu

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary

Noninvasive Aspergillus pulmonary diseases include allergic bronchopulmonary aspergillosis and aspergilloma. Treatment focuses on managing inflammation and fungal load, with options ranging from corticosteroids to antifungals and surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Have we resolved anything yet about sarcoidosis trials?

The European respiratory journal·2026
Same author

New proteomic biomarkers identified in plasma extracellular vesicles in sarcoidosis: a case-control matched study.

Frontiers in immunology·2026
Same author

Sarcoidosis: Disease mechanisms, diagnostic pathway and treatment.

Autoimmunity reviews·2026
Same author

Diagnostic accuracy of echocardiography in identifying heart failure related pleural effusions.

Respiratory medicine·2026
Same author

Signal regulating proteins (SIRPs) participate in sarcoidosis granuloma formation by promoting immune cell aggregation.

Respiratory research·2025
Same author

Clinical Approach to a Pleural Effusion.

Chest·2025

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Allergy & Immunology

Background:

  • Noninvasive Aspergillus pulmonary diseases arise from host responses to Aspergillus antigens or lung colonization.
  • Key examples include allergic bronchopulmonary aspergillosis and aspergilloma.
  • These conditions can lead to significant lung damage and complications if untreated.

Purpose of the Study:

  • To differentiate and describe noninvasive Aspergillus pulmonary diseases.
  • To outline clinical presentations and treatment strategies for allergic bronchopulmonary aspergillosis and aspergilloma.

Main Methods:

  • Review of clinical presentations and established treatment protocols for allergic bronchopulmonary aspergillosis and aspergilloma.
  • Discussion of host response mechanisms and fungal colonization.

Related Experiment Videos

  • Analysis of therapeutic options including anti-inflammatory, antifungal, and surgical interventions.

    • Main Results:

    • Allergic bronchopulmonary aspergillosis presents as asthma with bronchiectasis and potential lung injury, managed with corticosteroids and antifungals.
    • Aspergillomas form in devitalized lung tissue, posing a risk of life-threatening hemoptysis.
    • Surgical resection is definitive for aspergillomas but often not feasible; azoles and percutaneous antifungals are alternatives.

    Conclusions:

    • Noninvasive Aspergillus pulmonary diseases require distinct management approaches based on their underlying mechanisms.
    • Effective treatment involves addressing inflammation, reducing fungal burden, and managing complications like hemoptysis.
    • Further research into optimal therapeutic strategies for these challenging conditions is warranted.